{"url_path":"/fda/drug/recalls/D-0693-2026","section_key":"summary","section_title":"DRUG Recall: Blaine Labs Inc — TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy cap, Manufactured for: Trifluent Pharma, LLC. San Antonio, TX 78213. NDC 73352-520-01.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-04-08","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0693-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Blaine Labs Inc"},"word_count":91,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0693-2026\n\n**Recalling firm:** Blaine Labs Inc\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-04-08\n**Report date:** 2026-07-08\n\n## Product\nTRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy cap, Manufactured for: Trifluent Pharma, LLC. San Antonio, TX 78213. NDC 73352-520-01.\n\n## Reason\nCGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated\n\n## Affected lots\nLot #: BL3435, Exp. 11/06/26\n\n## Distribution\nNationwide in the USA"}